- House lawmakers back trade probe of China biotech, sequencingAt least 10 House lawmakers are backing a US trade panel’s probe of China’s biotech sector and related pricing practices, encouraging future executive action. In a letter sent to Secretary of the U…Endpoints · 8d ago↗ source
- Samsung Bio to step into peptides in $1.8B buy for PolyPeptideSamsung Biologics is set to branch out to peptide ingredient manufacturing with plans to buy Swiss CDMO PolyPeptide for $1.8 billion in cash. The purchase, announced Monday, would be the Korean ...Endpoints · 8d ago↗ source
- Pain drugmaker Latigo outlines plans to go publicThe Westlake-founded company specializes in non-opioid drugs that target sodium ion channels, and is now adding to what’s already been a busy month for the biotech IPO queue.